We all know that Hyderabad based Bharath Biotech is developing Covaxin for covid 19. On that update Today 70 country research deligates visited to Bharath Biotech on covaxin progress and information.
Covaxin successful evaluates phase 1 and phase 2 test, now it is ready for phase 3 trails over a bulk population nearly 26000 volunteers.It is the first vaccine ready for phase 3 test in india.
Bharath Biotech is developing Covaxin with the collaboration of Indian Council of Medical Research (ICMR) – National Institute of Virology (NIV). Covaxin is manufacturing in a Vero cell manufacturing process by following precise guidelines and precautions. It have excellent track record to defect covid 19 virus.
The update on the vaccine was presented to the scientists by Dr Krishna Ella, Chairman and Managing Director of Bharat Biotech.
Suchitra Ella, Joint Managing Director of Bharat Biotech said, Covaxin is a mile stone for Indians in covid 19 pandamic. Its progress attracts interest of world. It improves our prestage and status over the world.
